BAMS
HALO icon

Bellevue Asset Management (Switzerland)’s Halozyme HALO Stock Holding History

Bellevue Asset Management (Switzerland)’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$5.51M Buy
318,000
+72,000
+29% +$1.15M 0.84% 39
2015
Q3 		$3.3M Buy
246,000
+154,384
+169% +$3.1M 0.54% 56
2015
Q2 		$2.07M Hold
91,616
– – 0.29% 83
2015
Q1 		$1.31M Buy
+91,616
New +$1.32M 0.18% 110

Other funds holding HALO

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bellevue Asset Management (Switzerland)'s HALO Position: Q4 2015 in Review

Bellevue Asset Management (Switzerland) increased its Halozyme (HALO) stake by 29% in Q4 2015, buying an estimated $1.15M and bringing the position to 318,000 shares worth $5.51M. The position accounts for 0.84% of the portfolio, ranked #39.

Bellevue Asset Management (Switzerland) first reported a position in HALO in Q1 2015 and has held it in 4 quarters since. 166 funds tracked by Wall St. Rank hold HALO as of Q4 2015.

  • Bellevue Asset Management (Switzerland) held 318,000 shares of Halozyme worth $5.51M as of Q4 2015.
  • Bellevue Asset Management (Switzerland) bought 72,000 Halozyme shares in Q4 2015, an estimated $1.15M.
  • Halozyme made up 0.84% of Bellevue Asset Management (Switzerland)'s portfolio in Q4 2015, its #39 holding.
  • Bellevue Asset Management (Switzerland) first reported a position in Halozyme in Q1 2015 and has held it in 4 quarters since.
  • 166 funds tracked by Wall St. Rank held Halozyme as of Q4 2015.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q4 2015, filed 12 Feb 2016.